Ayala Pharmaceuticals EBIT margin
Что обозначает EBIT margin в Ayala Pharmaceuticals?
EBIT margin Ayala Pharmaceuticals Inc. является -5,723.60%
Какое определение для EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin компаний в Health Care сектор на NASDAQ по сравнению с Ayala Pharmaceuticals
Что делает Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.
Компании с ebit margin похож на Ayala Pharmaceuticals
- Entheon Biomedical имеет EBIT margin из -6,027.18%
- Green Hygienics имеет EBIT margin из -6,022.25%
- VYNE Therapeutics имеет EBIT margin из -5,849.18%
- Desert Metals имеет EBIT margin из -5,802.10%
- Rafael Inc имеет EBIT margin из -5,782.78%
- Clene Nanomedicine имеет EBIT margin из -5,778.73%
- Ayala Pharmaceuticals имеет EBIT margin из -5,723.60%
- Touchpoint имеет EBIT margin из -5,664.29%
- Lyra Therapeutics имеет EBIT margin из -5,567.64%
- Proseed India имеет EBIT margin из -5,566.02%
- Energous Corp имеет EBIT margin из -5,285.48%
- Orgenesis Inc имеет EBIT margin из -5,274.17%
- Zonetail имеет EBIT margin из -5,268.44%